Coronary Heart Disease Risk Profile of Women with PCOS: Collision of Evidence and Assumptions Evelyn Talbott, Dr.P.H. Kim Sutton-Tyrrell, Dr.P.H. Lewis.

Slides:



Advertisements
Similar presentations
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Advertisements

The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
Ethnic differences in risks and explanations for the cardiometabolic syndrome in the UK Nish Chaturvedi Professor of Clinical Epidemiology Imperial College.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
A comparison of overall health between Asian and Australians from European background: A west Australian study of Diet & Metabolic Syndrome Risk Factors.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
Polycystic Ovarian Syndrome
THE POLYCSTIC OVARY SYNDROME AND THE METABOLIC CARDIOVASCULAR SYNDROME.
Copyright © 2008 Delmar. All rights reserved. Chapter 21 Populations with Chronic Diseases.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
Lindsay Haney.
PCOS Polycystic Ovary Syndrome
The Metabolic Syndrome in PCOS. An international consensus group of the European Society for Human Reproduction and Embryology and the American Society.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.
Global impact of ischemic heart disease World Heart Federation, 2011.
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
METABOLIC SYNDROME From PubMed Health A service of the National Library of Medicine, National Institutes of Health. A.D.A.M. Medical Encyclopedia, Atlanta,
METABOLIC Syndrome: a Global Perspective
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
Polycystic Ovary Syndrome
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
Roy Homburg. 2 Polycystic ovary syndrome (PCOS) Criteria*: oligo- or anovulation clinical and/or biochemical signs of hyperandrogenism polycystic ovaries.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
KSU Biochemistry department sciences college Dr.Howaida Nounou Bnazeer AL-Mutiri Eman AL-Musa Ahood AL-Onazy Sua’ad AL-Otibie Amjad AL-Otibie.
Coagulation / Fibrinolytic Factors in PCOS. The Alternative Hypothesis : Conversely, PCOS women may be protected from later life onset of CHD by the altered.
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 15/10/58 1.
Calculated LDL by Age Cases vs. Controls Figure 1.
Diabetes National Diabetes Control Programme
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
ANOVULATION CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
Diagnosis of PCOS: 3998 Chinese cases NIH, Rotterdam criteria or AES ? NIH, Rotterdam criteria or AES ? Zi-Jiang Chen M.D., Ph.D Center for Reproductive.
Metabolic Syndrome Darwin Deen, MD, MS Albert Einstein College of Medicine Gina Lopez, MSII Sophie Davis School of Biomedical Education.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
The Metabolic Syndrome in a State Psychiatric Hospital Population Although studies of Metabolic Syndrome (MetS) have been conducted in private and community.
The short term effects of metabolic syndrome and its components on all-cause-cause mortality-the Taipei Elderly Health Examination Cohort Wen-Liang Liu.
Clinicaloptions.com/hepatitis NAFLD and NASH Prevalence in US Cohort Slideset on: Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty.
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
Facilitator: Pawin Puapornpong
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Chapter 7 Metabolic syndrome
Coagulation/Fibrinolytic Factors in PCOS
Prevalence Of Metabolic Syndrome And Assessment Of Nutritional And Biochemical Parameters Of Overweight And Obese Working Women 1Upasana, 2Chakravarty.
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Type 2 diabetes: Overlap of clinical conditions
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
The complications of obesity according to the values of BMI and waist circumference in an obese population of Tangier Nadia HAMJANE 1, Fatiha BENYAHYA1,2,
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Presentation transcript:

Coronary Heart Disease Risk Profile of Women with PCOS: Collision of Evidence and Assumptions Evelyn Talbott, Dr.P.H. Kim Sutton-Tyrrell, Dr.P.H. Lewis H. Kuller, M.D., Dr.P.H. Jeanne V. Zborowski, Ph.D. Dept. of Epidemiology Graduate School of Public Health University of Pittsburgh Evelyn Talbott, Dr.P.H. Dept. of Epidemiology Graduate School of Public Health

Learning Objective I To review some of the designs employed in the study of Cardiovascular Disease risk factors in women with PCOS To review some of the designs employed in the study of Cardiovascular Disease risk factors in women with PCOS  Retrospective  Prospective  Historical Prospective

Learning Objective II To provide an overview of the controversy in the literature to date linking PCOS and the risk of Heart Disease in women. To provide an overview of the controversy in the literature to date linking PCOS and the risk of Heart Disease in women.

Learning Objective III To more fully understand the metabolic parameters of PCOS in women in relation to Cardiovascular Disease risk over time and To more fully understand the metabolic parameters of PCOS in women in relation to Cardiovascular Disease risk over time and to discuss future research in this area. to discuss future research in this area.

Prevalence of Polycystic Ovary Syndrome (PCOS)  PCOS is a condition that affects 5-10% of women in the US.  It is a heterogeneous reproductive endocrine disorder.

Characteristics of PCOS U Chronic anovulation U Hyperandrogenemia U Insulin Resistance U Hyperinsulinemia U Obesity U Impaired Glucose Tolerance (IGT) U Central Adiposity

Etiology of Polycystic Ovary Syndrome (PCOS) U Primary dysregulation of ovarian steroidogenesis (Ehrmann, 1995); insulin post-receptor binding defect (Dunaif, 1992) U Multiple arrested follicles are present with increased ovarian stroma (pearl necklace effect) U Results in hypertrophied ovarian theca cells, elevated androgens, lack of a mid-cycle estradiol surge, and disrupted folliculogenesis (Barnes, 1997)

Atretic Follicle Thickened Capsule From: The Menstrual Cycle (1993), Ferin, Jewelewicz, and Warren The Polycystic Ovary Enlarged Ovary with Abundant Stroma

Differing Criteria of PCOS ULTRASOUND BIOCHEMICAL CLINICAL

Review of the Evidence related to CHD Risk and PCOS  Women with PCOS may be at increased risk of heart disease with increased prevalence of CHD risk factors: (LDL, HDL, triglycerides, hypertension and diabetes.)  However, the literature to date has been inconsistent.  Studies to date have been observational, largely consisting of case-control and cross sectional designs.

Click for larger picture

PCOS and Cardiovascular Risk U PCOS is associated with an increased prevalence of cardiovascular disease risk factors (Wild, 1988; Talbott, 1995) U In both lean and obese PCOS cases exhibited > fasting insulin levels (Slowinska-Srzednicka, 1991) U PCOS women have evidence of metabolic derangements similar to the Metabolic Cardiovascular Syndrome (Syndrome X) [dyslipidemia (  LDLc,  HDLc,  triglycerides), hypertension, and Type II diabetes]

Literature continued Conversely, other investigators have noted little difference in LDLc levels in thin versus obese PCOS cases and controls (Norman l992, Conway, l995). Conversely, other investigators have noted little difference in LDLc levels in thin versus obese PCOS cases and controls (Norman l992, Conway, l995). Earlier studies had small sample sizes and did not control for potential confounders Earlier studies had small sample sizes and did not control for potential confounders

Summary of Studies Linking Adverse Lipid Profiles in Women with PCOS Click for larger picture

Hyperinsulinemia, Insulin Resistance, and Impaired Hemostatic Function U Hyperinsulinemia and insulin resistance, as observed in PCOS, have been associated with increased CVD risk (Haffner, 1992; Savage, 1996; Reaven, 1998) U Recent evidence suggests hyperinsulinemia in PCOS correlates with increased CVD risk independent of obesity (Mather, 2000) U Increased risk may be a direct effect of elevated insulin or an indirect effect, through the influence of insulin on other metabolic processes (e.g. thrombosis, fibrinolysis) U Whether this translates into a true “ increased risk” of CHD is not known

CHD Mortality -Previous Literature To date, one historical prospective study of 768 PCOS women (McKeigue et al) undergoing wedge resection in the l has been conducted. There was no increased risk of cardiovascular disease noted in this population. To date, one historical prospective study of 768 PCOS women (McKeigue et al) undergoing wedge resection in the l has been conducted. There was no increased risk of cardiovascular disease noted in this population.

Types of Cohort Studies Click for larger picture

Pierpoint et al., J Clinical Epi, 51(7), 1998 Click for larger picture

Brief Literature Review In an earlier study of sudden cardiac death among women aged in Allegheny County (Talbott ’89), we noted an > rate of childlessness in ever married cases compared to controls (N=80 cases, 80 controls). In an earlier study of sudden cardiac death among women aged in Allegheny County (Talbott ’89), we noted an > rate of childlessness in ever married cases compared to controls (N=80 cases, 80 controls). Detailed reproductive histories,however, were not available. Detailed reproductive histories,however, were not available. The question of whether a reproductive endocrine abnormality such as PCOS was somehow linked to sudden cardiac death was intriguing. The question of whether a reproductive endocrine abnormality such as PCOS was somehow linked to sudden cardiac death was intriguing.

Risk of CHD in PCOS (Phase I l ) (Talbott, Guzick, Berga et. al.)  PCOS was a common enough diagnosis in medical practices that a large-scale study was possible.  The specific aim of our first study was to provide information on whether women with PCO have a greater incidence of known risk factors for CHD compared to age matched controls.

Methods  Using both historical and current records from the Reproductive Endocrine Clinic at Magee Women’s our goal was to identify 300 women with PCO and match them with 300 neighborhood controls.

Recruitment continued  Review of records of Dr. David Archer ( ) /Drs. David Guzick and Sarah Berga (2800 records, 10% met PCOS criteria)  Definition of PCOS :chronic anovulation and 1) evidence of clinical (hirsutism) or biochemical (Total T > 2.0 nmol/L) hyperandrogenism or 2) LH:FSH > 2.0

Research Methodology Clinic Visit Clinic Visit  Questionnaire data: demographics, lifestyle assessment, medical, reproductive, and menstrual histories  Anthropometrics (height, weight, waist and hip circumferences)  Blood pressure assessment  Lipids ( total cholesterol, triglycerides, LDLc, HDLc)  Fasting glucose and insulin

Results  Hormone levels PCOS cases vs controls  Blood lipid and insulin levels cases vs controls  Anthropometrics  Decided to look at age relationships

Selected Demographic and Reproductive Factors in PCOS Cases and Controls VARIABLES Age BMI HDL T LDLc Insulin Triglycerides WHR CASES (n=244) CONTROLS (n=244) * * * * * * * p < 0.01 ** p < 0.05

CHD Risk Factors by Age in PCOS Click for larger picture

CHD Risk Factors by Age in PCOS (cont.) Click for larger picture

Age Relationships  Risk profile by 10 year age groups  LDL levels: Women with PCOS had sig > LDL levels at ages less than 35 years  Insulin was higher in each age group than controls  BP was significantly greater than controls in the 35 to 44 group only

Control for BMI PCOS cases <40 yrs. showed significantly higher LDL levels than controls and this appears to be independent of BMI PCOS cases <40 yrs. showed significantly higher LDL levels than controls and this appears to be independent of BMI simple regression line of risk factors by age for cases and controls. simple regression line of risk factors by age for cases and controls.

Predictors of CHD Risk Factors in PCOS 1Triglyceride levels were log transformed *p<.05

Summary Younger women less than 40 with PCOS exhibit adverse lipid profiles Younger women less than 40 with PCOS exhibit adverse lipid profiles Approximately 50% of PCOS are insulin resistant as demonstrated by a GIR <5 Approximately 50% of PCOS are insulin resistant as demonstrated by a GIR <5